Table of Contents
Scholarly Research Exchange
Volume 2009, Article ID 974576, 4 pages
http://dx.doi.org/10.3814/2009/974576
Case Report

Hodgkin's Disease with Atypical Clinical Presentation, Associated with Ataxia-Telangiectasia

1Department of Pediatrics, Medical University-Plovdiv, 4000 Plovdiv, Bulgaria
2Department of Oncology and Hematology, Medical University-Plovdiv, 4000 Plovdiv, Bulgaria

Received 4 March 2009; Revised 3 May 2009; Accepted 12 May 2009

Copyright © 2009 M. I. Spasova et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Maricich and H. Zoghbi, “The cerebellum and the hereditary ataxias,” in Pediatric Neurology: Principles and Practice, K. F. Swaimann, S. Ashwal, and D. M. Ferriero, Eds., pp. 1241–1269, Mosby Elsevier, Philadelphia, Pa, USA, 2006. View at Google Scholar
  2. F. Hecht and B. K. Hecht, “Cancer in ataxia-telangiectasia patients,” Cancer Genetics and Cytogenetics, vol. 46, no. 1, pp. 9–19, 1990. View at Publisher · View at Google Scholar
  3. C. Sandoval and M. Swift, “Hodgkin's disease in ataxia-telangiectasia patients with poor outcomes,” Medical and Pediatric Oncology, vol. 40, no. 3, pp. 162–166, 2003. View at Publisher · View at Google Scholar · View at PubMed
  4. R. Bernstein, M. Pinto, and T. Jenkins, “Ataxia telangiectasia with evolution of monosomy 14 and emergence of Hodgkin's disease,” Cancer Genetics and Cytogenetics, vol. 4, no. 1, pp. 31–37, 1981. View at Publisher · View at Google Scholar
  5. D. C. Strollo, M. L. Rosado-de-Christenson, and J. R. Jett, “Primary mediastinal tumors—part II: tumors of the middle and posterior mediastinum,” Chest, vol. 112, no. 5, pp. 1344–1357, 1997. View at Publisher · View at Google Scholar
  6. R. C. Murphy, W. E. Berdon, C. Ruzal-Shapiro et al., “Malignancies in pediatric patients with ataxia telangiectasia,” Pediatric Radiology, vol. 29, no. 4, pp. 225–230, 1999. View at Publisher · View at Google Scholar
  7. B. Yalçin, M. T. Kutluk, Ö. Sanal et al., “Hodgkin's disease and ataxia telangiectasia with pulmonary cavities,” Pediatric Pulmonology, vol. 33, no. 5, pp. 399–403, 2002. View at Publisher · View at Google Scholar
  8. “Ataxia-telangiectasia,” Online Mendelian Inheritance in Men, September 2008, http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=208900.
  9. A. Stray-Pedersen, A. Borresen-Dale, E. Paus, C. R. Lindman, T. Burgers, and T. G. Abrahamsen, “Alpha fetoprotein is increasing with age in ataxia-telangiectasia,” European Journal of Paediatric Neurology, vol. 11, no. 6, pp. 375–380, 2007. View at Publisher · View at Google Scholar · View at PubMed
  10. H. Irsfeld, D. Körholz, G. Janßen, V. Wahn, and H. Schroten, “Fatal outcome in two girls with Hodgkin's disease complicating ataxia- telangiectasia (Louis-Bar syndrome) despite favorable response to modified-dose chemotherapy,” Medical and Pediatric Oncology, vol. 34, no. 1, pp. 62–64, 2000. View at Publisher · View at Google Scholar
  11. R. Y. J. Tamminga, W. V. Dolsma, J. A. Leeuw, and H. H. Kampinga, “Chemo- and radiosensitivity testing in a patient with ataxia telangiectasia and Hodgkin's disease,” Pediatric Hematology and Oncology, vol. 19, no. 3, pp. 163–171, 2002. View at Publisher · View at Google Scholar · View at PubMed
  12. M. F. Lavin, N. Gueven, S. Bottle, and R. A. Gatti, “Current and potential therapeutic strategies for the treatment of ataxia-telangiectasia,” British Medical Bulletin, vol. 81-82, no. 1, pp. 129–147, 2007. View at Publisher · View at Google Scholar · View at PubMed
  13. D. Körholz, A. Claviez, D. Hasenclever et al., “The concept of the GPOH-HD 2003 therapy study for pediatric Hodgkin's disease: evolution in the tradition of the DAL/GPOH studies,” Klinische Pädiatrie, vol. 216, no. 3, pp. 150–156, 2004. View at Publisher · View at Google Scholar · View at PubMed
  14. T. Niehues, G. Schellong, W. Dörffel et al., “Immunodeficiency and Hodgkin's disease: treatment and outcome in the DAL HD78-90 and GPOH HD95 studies,” Klinische Pädiatrie, vol. 215, no. 6, pp. 315–320, 2003. View at Publisher · View at Google Scholar · View at PubMed
  15. F. Pein, L. Iserin, F. de Vathaire, and J. Lemerle, “Cardiac toxicity of cancer treatment regimes in children and adolescents: physiopathology, clinical data and the paediatric oncologist's point of view,” Bulletin du Cancer, vol. 91, pp. S185–S191, 2004. View at Google Scholar
  16. Z. Miltényi, L. Gergely, and A. Illés, “Chronic pericarditis in Hodgkin's disease,” Orvosi Hetilap, vol. 143, no. 48, pp. 2687–2689, 2002. View at Google Scholar
  17. P. Zinzani, F. Gherlinzoni, G. Piovaccari et al., “Cardiac injury as late toxicity of mediastinal radiation therapy for Hodgkin's disease patients,” Hematologica, vol. 81, no. 2, pp. 132–137, 1996. View at Google Scholar
  18. C. Sandoval and M. Swift, “Treatment of lymphoid malignancies in patients with ataxia-telangiectasia,” Medical and Pediatric Oncology, vol. 31, no. 6, pp. 491–497, 1998. View at Publisher · View at Google Scholar